Combo Products Guidance Could Help Point Novel OTC Switches In Right Direction
This article was originally published in The Tan Sheet
Executive Summary
FDA delivers a draft GMPs guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device products. The document could be useful for firms interested in proposing novel Rx-to-OTC switches.